3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Esophageal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Advanced Solid Tumor
3
Neoplasm Metastasis
2
Melanoma
2
Esophageal Squamous Cell Carcinoma
2
Advanced Solid Tumour
2
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Simpson-Golabi-Behmel syndrome
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasm, Residual
1
Nasopharyngeal Carcinoma
1
Metastatic Solid Tumors
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Diabetes Mellitus
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Advanced Solid Tumors
1
Advanced Malignancies
1
Adenocarcinoma Of Esophagus
1
Interventions
Gemcitabine
26
Specimen Handling
20
130-nm albumin-bound paclitaxel
18
Magnetic Resonance Spectroscopy
13
Irinotecan
13
Biopsy
12
Fluorouracil
11
Leucovorin
10
Oxaliplatin
9
Cyclophosphamide
8
pembrolizumab
7
fludarabine
7
Albumin-Bound Paclitaxel
7
Cisplatin
6
Cetuximab
6
Nivolumab
5
durvalumab
4
Taxes
4
Radiosurgery
4
Pemetrexed
4
Capecitabine
4
zimberelimab
3
trastuzumab deruxtecan
3
olaparib
3
irinotecan sucrosofate
3
dehydroftorafur
3
aldesleukin
3
Radiotherapy
3
Immunoglobulin G
3
Exercise
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pancreatic Neoplasms
×
tislelizumab
×
30 days
×
Clear all
No trials found.